Trademark: 87434811
Word
KIENDRA
Status
Dead
Status Code
606
Status Date
Monday, January 11, 2021
Serial Number
87434811
Mark Type
4000
Filing Date
Wednesday, May 3, 2017
Published for Opposition
Tuesday, April 10, 2018
Abandoned Date
Monday, January 11, 2021

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; all of the aforementioned for use in prescription channels

Trademark Events
Jan 11, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 11, 2021
Abandonment - No Use Statement Filed
Jun 6, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 4, 2020
Extension 4 Granted
Jun 4, 2020
Extension 4 Filed
Jun 4, 2020
Teas Extension Received
Dec 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 3, 2019
Extension 3 Granted
Dec 3, 2019
Extension 3 Filed
Dec 3, 2019
Teas Extension Received
Jun 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 3, 2019
Extension 2 Granted
Jun 3, 2019
Extension 2 Filed
Jun 3, 2019
Teas Extension Received
Dec 6, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 4, 2018
Extension 1 Granted
Dec 4, 2018
Extension 1 Filed
Dec 4, 2018
Teas Extension Received
Jun 5, 2018
Noa E-Mailed - Sou Required From Applicant
Apr 10, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 10, 2018
Published For Opposition
Mar 21, 2018
Notification Of Notice Of Publication E-Mailed
Mar 8, 2018
Approved For Pub - Principal Register
Mar 7, 2018
Teas/Email Correspondence Entered
Mar 7, 2018
Correspondence Received In Law Office
Mar 5, 2018
Teas Response To Suspension Inquiry Received
Feb 23, 2018
Notification Of Letter Of Suspension E-Mailed
Feb 23, 2018
Letter Of Suspension E-Mailed
Feb 23, 2018
Suspension Letter Written
Jan 26, 2018
Teas/Email Correspondence Entered
Jan 26, 2018
Correspondence Received In Law Office
Jan 26, 2018
Teas Response To Suspension Inquiry Received
Jan 17, 2018
Report Completed Suspension Check Case Still Suspended
Jan 16, 2018
Assigned To Lie
Jun 9, 2017
Notification Of Letter Of Suspension E-Mailed
Jun 9, 2017
Letter Of Suspension E-Mailed
Jun 9, 2017
Suspension Letter Written
Jun 2, 2017
Assigned To Examiner
May 8, 2017
New Application Office Supplied Data Entered In Tram
May 6, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24